RxDoctor Payments Data

Bradon Wilhelmi, MD

Plastic and Reconstructive Surgery · Louisville, KYNPI 1417943549

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 93.7% of the total across 79 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 18 manufacturers reported payments, led by RTI Surgical, Inc at 31.3% of the total.

$4,769in general payments, 2019–2025

Across 79 payments — averaging $60.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • RTI Surgical, Inc$1K
  • AbbVie$1K
  • Integra Lifesciences Corporation$757
  • Smith+Nephew$362
  • Mentor Worldwide LLC$284
  • Axogen$140
  • plus $603 from 12 others

What the payments were for

  • Food & beverage$4,46694%
  • Other$3026%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,769 in reported general payments places this provider in the 65th percentile of 43 plastic and reconstructive surgery providers in Kentucky.

See all plastic and reconstructive surgery providers in Kentucky

Medicare billing

Part B allowed, 2024
$47,670
Medicare patients
68
Services billed
227

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ciprofloxacin Hcl18$183

Paid to pharmacies, not to this prescriber.

Other plastic and reconstructive surgery in Louisville

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →